Colgate-Palmolive Company $CL Stock: Signal Advisors Wealth LLC Grows Stake

Signal Advisors Wealth LLC lifted its stake in Colgate-Palmolive Company (NYSE:CL) by 637.7% in the third quarter, HoldingsChannel reports. The fund owned 20,022 shares of the company’s stock after purchasing an additional 17,308 shares during the quarter. Signal Advisors Wealth LLC’s holdings in Colgate-Palmolive were worth $1,708,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Foster Group Inc. boosted its stake in Colgate-Palmolive by 152.1% during the 3rd quarter. Foster Group Inc. now owns 11,547 shares of the company’s stock valued at $985,000 after purchasing an additional 6,967 shares in the last quarter. Krilogy Financial LLC raised its stake in shares of Colgate-Palmolive by 255.2% in the 3rd quarter. Krilogy Financial LLC now owns 15,715 shares of the company’s stock worth $1,341,000 after buying an additional 11,291 shares in the last quarter. Affinity Capital Advisors LLC raised its stake in shares of Colgate-Palmolive by 46.4% in the 3rd quarter. Affinity Capital Advisors LLC now owns 5,810 shares of the company’s stock worth $496,000 after buying an additional 1,841 shares in the last quarter. Forvis Mazars Wealth Advisors LLC raised its stake in shares of Colgate-Palmolive by 46.3% in the 3rd quarter. Forvis Mazars Wealth Advisors LLC now owns 24,449 shares of the company’s stock worth $2,086,000 after buying an additional 7,738 shares in the last quarter. Finally, First Financial Corp IN lifted its holdings in shares of Colgate-Palmolive by 212.7% in the third quarter. First Financial Corp IN now owns 6,536 shares of the company’s stock valued at $558,000 after buying an additional 4,446 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts recently weighed in on CL shares. Piper Sandler decreased their target price on Colgate-Palmolive from $98.00 to $95.00 and set an “overweight” rating for the company in a research note on Monday, September 21st. Evercore lifted their target price on Colgate-Palmolive from $100.00 to $101.00 and gave the stock an “outperform” rating in a report on Thursday, October 8th. Morgan Stanley reaffirmed an “overweight” rating and set a $104.00 target price (up from $100.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $101.00 price target (up from $99.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Finally, Jefferies Financial Group reissued a “hold” rating and issued a $89.00 price target (up from $88.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Thirteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $98.11.

Insider Transactions at Colgate-Palmolive

In other news, CEO Noel R. Wallace sold 161,021 shares of the business’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the sale, the chief executive officer directly owned 362,231 shares of the company’s stock, valued at $33,296,273.52. The trade was a 30.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director John T. Cahill sold 4,170 shares of the company’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total value of $389,352.90. Following the sale, the director directly owned 28,373 shares of the company’s stock, valued at approximately $2,649,187.01. This represents a 12.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 175,191 shares of company stock valued at $16,110,903 in the last three months. 0.43% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Trading Up 3.2%

Shares of NYSE:CL opened at $92.80 on Thursday. The stock has a market capitalization of $73.98 billion, a price-to-earnings ratio of 36.83, a PEG ratio of 4.30 and a beta of 0.33. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.67 and a current ratio of 1.03. The company has a 50 day moving average price of $89.04 and a 200 day moving average price of $88.93.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.04. The firm had revenue of $5.36 billion for the quarter, compared to analyst estimates of $5.36 billion. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The firm’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.92 earnings per share. On average, research analysts anticipate that Colgate-Palmolive Company will post 3.87 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be paid a dividend of $0.53 per share. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 84.13%.

About Colgate-Palmolive

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.